FemHealth Ventures’ Post

Venture Capital News - Venture Capital News Headlines

🚀RED.Health Raises $20M in Series-B Round, Led by Jungle Ventures 🌱 I am thrilled to announce that RED.Health, a leading healthcare technology company, has secured $20M in its Series-B funding round, with Jungle Ventures leading the investment. This significant financial backing will enable RED.Health to further develop and expand its innovative healthcare solutions, driving the future of personalized and accessible healthcare. The latest funding round underscores the confidence and support from leading investors, showcasing the recognition of RED.Health's pioneering work in transforming healthcare delivery. The infusion of capital will propel the company towards the next phase of growth, driving innovation and catalyzing the advancement of healthcare technology. This milestone wouldn't have been possible without the unwavering dedication of our exceptionally talented team and the unwavering support of our valued partners and stakeholders. I am immensely proud of our team's relentless commitment to revolutionize healthcare and lead meaningful change in the industry. This funding paves the way for exciting developments and empowers us to continue our mission of leveraging technology to enhance healthcare outcomes and access for all. We remain deeply committed to advancing the future of healthcare, and this latest funding round will be instrumental in propelling us towards our vision. I extend my heartfelt gratitude to our investors, partners, and everyone who has been a part of this incredible journey. Together, we will continue to drive innovation, impact lives, and shape the future of healthcare. #REDHealth #HealthcareInnovation #SeriesB #JungleVentures #HealthTech #FundingRound #FutureOfHealthcare Note: AI-powered post. May contain errors.

What an insightful article in Vator’s “Meet the VC” series about Aegis Ventures co-founder and managing partner John Beadle, and the company creation platform built to partner with health systems!   The partnership between Northwell Health and Aegis Ventures has resulted in the development and launch of several healthcare companies, including Caire, Ascertain and Optain.   Aegis will be expanding its scope by working within an expanded healthcare system ecosystem through its Digital Consortium. We believe healthcare systems are best suited to understand and prioritize the changes needed in healthcare, and possess the knowledge and know-how to fix these problems head-on. Through our partnership with Aegis, Northwell Holdings has been able to explore creating these solutions on a commercial scale so they can be utilized by organizations across the healthcare landscape. The advent of the Digital Consortium marks an important milestone for how health systems can co-develop solutions and unlock the value inherent in our collective enterprises to drive catalytic change and improve care delivery and better support the efforts of our coworkers. Richard Mulry, Michael Dowling, John Noseworthy, M.D., Mark Michalski, Jeff Dunkel https://lnkd.in/etRk3-Yw

FemHealth Ventures, which invests in companies focused on women’s health, has closed a $32 million debut fund despite a difficult fundraising environment for new venture firms! Maneesha Ghiya says they expect to invest the fund in about 20 companies. FemHealth Ventures invests in 4 categories: - Drugs: Pills, injections, or creams to treat a condition - Devices: Implants or instruments placed on or in the body to treat a condition - Diagnostics: Tests, imaging, or tools to identify a condition - Digital: Apps to track or treat a condition Good luck, #femtech founders who are raising money! #femtech #womenhealth #venturecapital #fundrasing #startups #raisingmoney Kathrin Folkendt Kamila Staryga Ida Tin Jillian Levovitz, MBA Gleb Babiy Elad Katz Natallia Miranchuk

Join Andrew Merken (Burns & Levinson LLP), Rowan Cade (Drive), Nicolas Cindric (Yahara Ventures), Manasa Gummalla (J.P. Morgan Asset Management), and Natasha Bonett DeLong (Rex Health Ventures) at RESI South 2024, March 25-27, a hybrid conference, in-person (March 25), and online partnering (March 26-27), for the Corporate VC Panel. Corporate venture capital firms are an important source of capital for early-stage companies. Many major pharmaceuticals and large corporations have set up a corporate investment arm to identify early-stage companies. Strategically and financially driven in varying degrees, the implications of working with CVCs are huge, as the resources, network, and guidance provided by the CVC and the associated parent company are incredibly valuable to an entrepreneur who is actively growing their business. This panel will discuss the following topics and more: 1: How are CVCs different from traditional VCs? 2: How strategically vs. financially are CVCs driven, and how does this affect their decision-making process? 3: How closely does the CVC communicate with the parent company? 4: What does working with a CVC entail? There is still time to Register for RESI SOUTH! USE CODE MKT200 FOR $200 OFF YOUR REGISTRATION: https://lnkd.in/evdB8_as #RESI #RESISOUTH #RESIATLANTA #Startups #Investment #Pitch #Earlystage #Fundraising #Healthcare #Lifescience

2024 starts off with its first 'whoa' moment. Venture capital firm General Catalyst to buy Ohio health system Summa Health. Why does it matter? First of all, it will convert Summa Health into a for-profit health system, and second, it will integrate a patient-facing health delivery operation with one of the largest developers and sellers of health care technology. It is also remarkable because while private equity (PE) has been engaged in this scale of M&A, it is rare for a VC firm to invest outside of the 'start-up' market. and focus a major investment in a mature company with an established proof of concept. Could this be the beginning of a new trend in healthcare M&A? #healthcareinnovation #healthcare #valuebasedcare #valuebasedhealthcare #employeehealth #employeebenefits #payor #providercredentialing #providercontracting #providerrecruitment #providers #directprimarycare #cigna #cignahealthcare #evernorth #evernorthaccountablecare

Something weird happened today in healthcare news. General Catalyst, a major VC fund, made a bold but weird move by acquiring Summa Health, a nonprofit hospital in Akron, Ohio. General Catalyst has a portfolio of over 99 healthcare companies. Safe to say that some of these companies are grappling with breaking into the healthcare market. Its merciless arena. " ARE YOU NOT ENTERTAINED!?" Shoutout Gladiator. Hospitals are notoriously archaic, which is funny to me, because this was their disruptive play. I think I like it.... They have brought in a former CEO from Intermountain Healthcare, a forward-thinking system. Nevertheless, this acquisition leaves me with a myriad of questions—legal, ethical, and concerning potential conflicts of interest. And let's not forget that a substantial portion of healthcare is government-funded. You pay taxes, do you want your tax dollars ending up in VC coffers? So, here's my question to you all: Should VC firms own hospitals? What might this mean for product/market fit, creating momentum, or the emergence of more vertically integrated VC firms in the healthcare market? #HealthcareInnovation #VCinHealthcare #FutureOfHealthcare https://lnkd.in/gUQ29VyJ

Are you curious about the world of Healthcare and Finance? Me too. 👨⚕️💲🌍 Episode 36 of the Digital Health Heavyweights Podcast is here, and it's an absolute must-listen! 🌟 Tune in as we delve deep into the world of healthcare and finance with none other than Branden Fini, Partner at Providence Ventures. Brandon and I chat about it all! From healthcare bottlenecks, building teams, founder traits, advice for founders and more. We cover the importance of understanding the pain points in healthcare and the need for a comprehensive set of expertise in the management team. He emphasizes the value of trust, pattern recognition, and being coachable in evaluating founders and management teams. I like that one particularly, being coachable is super important. 👆 Branden also discusses the unique value proposition of Providence Ventures and the future of the firm. We even discuss what sets a VC apart and how to win deals at a good price. Never undervalue the building of trust and rapport with founders, as well as the importance of understanding the pain points of the healthcare industry. 🎯 Brandon's advice to founders? Focus on solving a specific problem and to have a clear go-to-market strategy. Our favorite Takeaways: • 💼 Providence Ventures offers a unique value proposition with its strategic platform and connections to stakeholders. • 🔮 The future of Providence Ventures involves scaling its strategy and continuing to attract top talent. To stand apart and win deals at a good price, venture capitalists need to have a track record of adding value to portfolio companies and showcasing successful partnerships. • 🤝 Building trust and rapport with founders is crucial in the venture capital industry, as founders want to work with people they like and trust. • 💡 Founders should focus on solving a specific problem and have a clear go-to-market strategy, including understanding the pain points of the healthcare industry and integrating their product into existing workflows. • 🚩 Red flags in founding teams include being overcapitalized, as it can lead to excessive spending and compressed investor returns. Don't miss out on this insightful conversation! Tune in now to gain exclusive access to Branden's invaluable expertise. 🔥 #DigitalHealth #VentureCapital https://lnkd.in/dffGmQar

Phenomenal session with Steve Kraus, Partner at Bessemer Venture Partners (BVP), the longest standing venture firm in the world! With the firm’s origins in 1911, Steve shares tremendous insights on investing and market cycles over the past century plus. Key takeaways: - BVP has dedicated healthcare investing practice for 40 years - Believes in providing 1 1=3 to portfolio companies by providing 2 partners on each portfolio company with 2 different areas of expertise, knowledge, networks - 2019 to early 2021 was a bubble. There are 2 types of bubbles. One bubble where asset valuation is inflated and asset not great (such as the dot com bubble). Bubble where asset valuation is mispriced and assets are good (the bubble we just had). Thus there’s a valuation issue not a fundamental unit economics issue with many companies. - Valuations have reset and we are at the bottom. At peak, some of the industry traded at 10x-15x forward revenue multiples; today they are at 3.5x; and historical average is around 7x-10x. - A few years ago, with the first cohort of health tech IPOs, some did not work and some were successful such as Oak Street Health, One Medical, Signify Health, Teladoc Health. Lots of great companies were born and their stock prices are down; they are good assets but misvalued and will come out of the trough. - There are several private companies that are scaling to hundreds of millions in revenue, and when public markets rise, these companies will propel the industry. - There’s money to be made in the application of AI and technologies that are generative in nature and can automate laborious manual processes Link to episode here: https://lnkd.in/dpG7baXC. Thank you for watching The HLTH Daily Show! #health #healthcare #wellness #ceo #leadership #innovation #technology #digital #transformation #business #patientcare #data #ai #artificialintelligence #generativeai #venturecapital #privateequity #investing #entrepreneurship #founders #startups #hlth HLTH Oak Street Health One Medical Signify Health Teladoc Health #money #wealth

Accelerate Fund III, an early-stage angel co-investment fund in Alberta, announced its investment in the CARE Group of Companies, an Alberta-based health innovation and technology company focused on digital mental health technologies and programs. CARE Group’s financing round attracted more than $2 million and included participation from Accelerate Fund, strategic angel investors and family offices. CARE Group’s platforms integrate virtual care with real-time monitoring and personalized patient engagement, delivering improved health outcomes at a lower cost. Capital for Accelerate Fund comes from the Alberta Enterprise Corporation, an independent corporation formed by the Alberta government. #HealthTech #DigitalHealth #MentalHealthTech #AngelInvestment #AccelerateFund #CAREGroup #Innovation #AlbertaTech #VirtualCare #StartupFunding #PatientEngagement #HealthcareInnovation #TechInvestment #EarlyStageFunding